OverviewChartNewsTraderScreen

L&S Knock-Out ZEG/  DE000LX0BQS3  /

Lang & Schwarz
10/06/2024  22:58:16 Chg.+0.10 Bid22:58:16 Ask22:58:16 Underlying Strike price Expiration date Option type
6.44EUR +1.58% 6.44
Bid Size: -		 6.54
Ask Size: -		 ASTRAZENECA PLC D... 85.8631 - 31/12/2078 Call
GlobeNewswire 10/06 Sermonix Pharmaceuticals Announces Breast Cancer Research Publication of Paper Examining Lasofoxifen...
GlobeNewswire 10/06 Model N Named one of Fortune Media and Great Place to Work ® 2024 Best Workplaces in the Bay Area
GlobeNewswire 10/06 Centessa Pharmaceuticals Strengthens Executive Leadership with Appointment of John Crowley CPA, as C...
GlobeNewswire 28/05 Cellectis Reports Financial Results for First Quarter 2024
TeleTrader 21/05 AstraZeneca to deliver $80B total revenue by 2030
TeleTrader 20/05 AstraZeneca to build $1.5B plant in Singapore
GlobeNewswire 08/05 Annual NMDP Gala in New York Raises More Than $560,000, Enabling More Patients to Receive Life-Savin...
GlobeNewswire 06/05 FibroGen Reports First Quarter 2024 Financial Results
GlobeNewswire 06/05 Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
GlobeNewswire 02/05 Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant R...
GlobeNewswire 29/04 Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023
TeleTrader 25/04 Europe opens mostly down after corporate earnings
TeleTrader 25/04 AstraZeneca Q1 revenue jumps 19% to $12.7B
GlobeNewswire 28/03 HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Pati...
TeleTrader 19/03 AstraZeneca to acquire Fusion for $2 billion
GlobeNewswire 18/03 AAFA Statement in Response to AstraZeneca Asthma Inhaler Cost Announcement
TeleTrader 14/03 AstraZeneca to acquire Amolyt Pharma for $1.05B
GlobeNewswire 14/03 Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca
GlobeNewswire 28/02 HUTCHMED Reports 2023 Full Year Results and Provides Business Updates
GlobeNewswire 26/02 FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire 26/02 FibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States and Other AstraZenec...
GlobeNewswire 22/02 Gracell Biotechnologies Acquisition Completed
GlobeNewswire 22/02 Sodexo and AstraZeneca extend their global partnership for a further 5 years.
GlobeNewswire 20/02 Gracell Biotechnologies Announces Shareholders’ Approval of Merger Agreement
TeleTrader 09/02 Europe mostly lower premarket amid German CPI, earnings